CMS IndusLaw advised healthcare-focused private equity firm OrbiMed Asia on its USD32 million investment in Indian company Redcliffe Hygiene, which operates the brand Pee Safe.
OrbiMed Asia led the series C fundraising transaction, comprising a combination of primary and secondary investments, with the former structured in three tranches. It involved a complex shareholder base of 55 sellers, including members of the promoter group, and resulted in the exit of certain institutional investors.
Pee Safe operates in the women’s hygiene and wellness segment, offering a portfolio of products spanning personal hygiene, sexual wellness and preventative healthcare.
Founding and senior partner Kartik Ganapathy, who provided strategic guidance, led the CMS IndusLaw team, along with partner Minhaz Lokhandwala, principal associate Maitri Parekh and associate Sanjana Sreenath.
The due diligence team comprised partner Lokhandwala, Parekh, and associates Abhinav A, Aditya Jain, Radhika Chauhan and Vatsal Agarwal.
DSK Legal advised Redcliffe Hygiene.
